Risk analysis of bloodstream infection during long-term left ventricular assist device support

Annals of Thoracic Surgery

Volumn 94, Issue 5, 2012, Pages 1387-1393

  Toda, Koichi ^a   Yonemoto, Yumiko ^a   Fujita, Tomoyuki ^a   Shimahara, Yusuke ^a   Sato, Shyunsuke ^a   Nakatani, Takeshi ^a   Kobayashi, Junjiro ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACINETOBACTER; ADULT; ARTICLE; BACILLUS; BLOODSTREAM INFECTION; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; ENTEROBACTER; ENTEROCOCCUS; FEMALE; HEART FAILURE; HEART RIGHT VENTRICLE FAILURE; HEART TRANSPLANTATION; HUMAN; IMPLANTATION; KLEBSIELLA; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RECURRENT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SERRATIA; STAPHYLOCOCCUS CAPITIS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS LUGDUNENSIS; STENOTROPHOMONAS MALTOPHILIA; SURVIVAL RATE;

ADULT; BACTEREMIA; FEMALE; HEART-ASSIST DEVICES; HUMANS; MALE; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84867812235     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2012.03.021     Document Type: Article

References (21)

1. M.S. Slaughter, J.G. Rogers, C.A. Milano Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
2. J.M. Schaffer, J.G. Allen, E.S. Weiss Infectious complications after pulsatile-flow and continuous-flow left ventricular assist device implantation J Heart Lung Transplant 30 2011 164 174
3. W.L. Holman, J.K. Kirklin, D.C. Naftel Infection after implantation of pulsatile mechanical circulatory support devices J Thorac Cardiovasc Surg 139 2010 1632 1636
4. V.K. Topkara, S. Kondareddy, F. Malik Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era Ann Thorac Surg 90 2010 1270 1277
5. W.L. Holman, S.J. Park, J.W. Long Infection in permanent circulatory support: experience from the REMATCH trial J Heart Lung Transplant 23 2004 1359 1365
6. S.M. Gordon, S.K. Schmitt, M. Jacobs Nosocomial bloodstream infections in patients with implantable left ventricular assist devices Ann Thorac Surg 72 2001 725 730
7. T. Nakatani Heart transplantation Circ J Supp A 2009 A-55 A-60
8. J.S. Garner, W.R. Jarvis, T.G. Emori, T.C. Horan, J.M. Hughes CDC definitions for nosocomial infections, 1988 Am J Infect Control 16 1988 128 140
9. L.G. Bekeris, J.A. Tworek, M.K. Walsh, P.N. Valenstein Trends in blood culture contamination: a College of American Pathologists Q-Tracks study of 356 institutions Arch Pathol Lab Med 129 2005 1222 1225
10. R. Chinn, W. Dembitsky, L. Eaton Multicenter experience: prevention and management of left ventricular assist device infections ASAIO J 51 2005 461 470
11. R.L. Kormos, J.J. Teuteberg, F.D. Pagani Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes J Thorac Cardiovasc Surg 139 2010 1316 1324
12. E.A. Rose, A.C. Gelijns, A.J. Moskowitz Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
13. L.W. Miller, F.D. Pagani, S.D. Russell Use of a continuous-flow device in patients awaiting heart transplantation N Engl J Med 357 2007 885 896
14. R.C. Bone, R.A. Balk, F.B. Cerra Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine Chest 101 1992 1644 1655
15. United Network for Organ Sharing Allocation of thoracic organs policy 3.7 Richmond VA: United Network of Organ Sharing http//www.unos.org
16. R.S. Poston, S. Husain, D. Sorce LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection J Heart Lung Transplant 22 2003 914 921
17. T. Sasaoka, T.S. Kato, K. Komamura Improved long-term performance of pulsatile extracorporeal left ventricular assist device J Cardiol 56 2010 220 228
18. G.E. Stein, E.M. Wells The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid Curr Med Res Opin 26 2010 571 588
19. R. John, F.D. Pagani, Y. Naka Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables J Thorac Cardiovasc Surg 140 2010 174 181
20. A. Zierer, S.J. Melby, R.K. Voeller Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support Ann Thorac Surg 84 2007 515 520
21. A.R. Schulman, T.P. Martens, M.J. Russo Effect of left ventricular assist device infection on post-transplant outcomes J Heart Lung Transplant 28 2009 237 242